TP53 and breast cancer: Annual rates of contralateral breast cancer (and proportion of synchronous breast cancers) were highest among TP53 carriers at 7.03% (4.3%), followed by BRCA1 carriers at 3.57% (1.8%) and BRCA2 carriers at 2.63% (1.5%) (see Table 1).